Call Today for a FREE Confidential Case Review
Toll-Free 24/7 (866) 920-0753

FDA Sends “RegeneSlim” a DMAA Warning Letter

FDA Sends “RegeneSlim” a DMAA Warning Letter

September 13, 2012 — The U.S. Food and Drug Administration (FDA) has sent another warning letter to a dietary supplement manufacturer who uses DMAA in their product. Although DMAA is not banned in the United States, the FDA is warning that products containing DMAA pose serious health risks. Furthermore, these products cannot be sold because synthetically-produced DMAA is not a dietary ingredient, and manufacturers have never submitted a New Dietary Ingredient (NDI) notification to the FDA.

The company that received the warning letter is Regeneca Inc., which makes the product “RegeneSlim.” It is advertised as an “Appetite Control and Weight Loss Management” supplement. DMAA is listed on the product label as “dimethylamylamine.” It is also sometimes known as methylhexanamine or geranium oil/extract. The ingredient has mild stimulant properties, similar to ephedrine, but weaker.

According to the FDA,

“To the best of FDA’s knowledge, there is no history of use or other evidence of safety establishing that dimethylamylamine will reasonably be expected to be safe as a dietary ingredient. In fact, dimethylamylamine narrows the blood vessels and arteries, which increases cardiovascular resistance and frequently leads to elevated blood pressure.  This rise in blood pressure may increase the work of the heart such that it could precipitate a cardiovascular event, which could range from shortness of breath to tightening of the chest and/or a possible myocardial infarction (heart attack).”

The FDA also added, “synthetically produced dimethylamylamine is not a dietary ingredient.”

The FDA has asked Regeneca to immediately cease distribution of RegeneSilm and any other products containing dimethylamylamine. Under the Dietary Supplement Health and Education Act (DSHEA) of 1994, dietary ingredients introduced after October 15, 1994 must submit a New Dietary Ingredient (NDI) notification to the FDA. Failure to do so could result in warning letters and enforcement action.

The content of this warning letter is very similar to the content in 10 other warning letters the FDA sent to other DMAA manufacturers in May 2012. Some have fought back — Nutrex responded to a warning letter by presenting evidence that DMAA is a safe, natural substance derived from the geranium plant. There is very little evidence linking DMAA to a botanical source, and most qualified experts agree that it is very unlikely that DMAA is natural.

Do I have a DMAA Lawsuit?

The Schmidt Firm, PLLC is currently accepting DMAA induced injury cases in all 50 states. If you or somebody you know has been injured by DMAA, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Dietary Supplement Litigation Group or call toll free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation’s leading plaintiffs' law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firm's reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.